Evidence map›Paper›PMID 2317202›Full record

ArticleThe Biochemical journal1990

Stimulus-response coupling in human platelets activated by monoclonal antibodies to the CD9 antigen, a 24 kDa surface-membrane glycoprotein.

R C Carroll, R E Worthington, C Boucheix

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Tetraspanins and vascular functions.Cardiovascular research · 2009
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

R C CarrollDepartment of Medical Biology, University of Tennessee Medical Center, Knoxville 37920.
R E Worthington
C Boucheix
Hôpital Paul-Brousse · FR

Funding

PLATELET CYTOSKELETAL ASSEMBLY &FUNCTIONR01HL034445 · NHLBI · UNIVERSITY OF TENNESSEE KNOXVILLE · PI CARROLL, ROGER C · 1985 to 1989
–
ERYTHROPOIESIS AND RESISTANCE TO LEUKEMIAR23CA042902 · NCI · UNIVERSITY OF TENNESSEE KNOXVILLE · PI WORTHINGTON, RONALD E · 1986 to 1988
–
NCI NIH HHS CA-42902NHLBI NIH HHS HL-34445
6 · The paper itself

Abstract

The CD9 molecule is a 24 kDa surface-membrane glycoprotein present on platelets and a variety of haematopoetic and non-haematopoetic tissues. In the present study we utilized specific inhibitors of thromboxane A2 (TxA2) formation (aspirin), protein kinase C [H-7 [1-(5-isoquinolinesulphonyl)-2-methylpiperazine]] and autocrine stimulation by secreted ADP (apyrase) to modify platelet activation by a monoclonal antibody ALB-6 to the CD9 antigen. This activation is only partially inhibited by aspirin alone but, in combination with either H-7 or apyrase, more than 50% inhibition of platelet aggregation and secretion was observed. This combination of inhibitors was also required to inhibit effectively the phosphorylation of myosin light chain and the 47 kDa substrate of protein kinase C. Intracellular Ca2+ flux monitored by the fluorescent dye fura-2 showed that this was almost completely mediated by the aspirin-sensitive TxA2 pathway. We suggest that the aspirin-insensitive pathway is primarily mediated by phospholipase C formation of diacylglycerol to activate protein kinase C. The inhibition by apyrase suggests a strong dependency on autocrine stimulation by secreted ADP to fully activate both phospholipase C and express fibrinogen-binding sites mediating platelet aggregation. This alternate pathway of phospholipase C activation by ALB-6 may be mediated by cytoplasmic alkalinization [monitored by SNARF-1 (5'(6')-carboxy-10-bismethylamino-3-hydroxy-spiro-[7H- benzo[c]xanthine-1',7(3H)-isobenzofuran]-3'-one) fluorescence of the dye]. Both activation pathways are dependent on intact antibodies, since F(ab')2 fragments of SYB-1, a monoclonal antibody against the CD9 antigen with activation characteristics identical with those of ALB-6, do not elicit activation. Besides thrombin, collagen is another physiological agonist shown to induce aspirin-insensitive activation. Similarities to ALB-6 in collagen sensitivity to apyrase in combination with aspirin inhibitors were noted with respect to aggregation and secretion, as well as a complete block of Ca2+ flux by aspirin. However, it is unlikely that collagen activation is mediated by the CD9 antigen, since SYB-1 F(ab')2 fragments had no effect on collagen activation and aspirin also completely blocked the alkalinization response to collagen, in contrast with ALB-6.

Indexed as

Antigens, CDMembrane GlycoproteinsPlatelet Activation1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAdenosine DiphosphateAntibodies, MonoclonalAntigens, DifferentiationAspirinBlood PlateletsCalciumCollagenHumansHydrogen-Ion ConcentrationImmunoglobulin Fab FragmentsIsoquinolinesPhosphoproteins1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAdenosine DiphosphateAntibodies, MonoclonalAntigens, CDAntigens, DifferentiationAspirinCalciumCD9 protein, humanCollagenImmunoglobulin Fab FragmentsIsoquinolinesMembrane GlycoproteinsPhosphoproteinsPiperazinesPlatelet Membrane GlycoproteinsProtein Kinase CSerotoninTetraspanin 29Thromboxane A2

Identifiers

PMID2317202
PMCPMC1131164
OpenAlexW2416867607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.